Skip to content

The Effect of Laser Therapy and stretching exercises on neuropathic pain with spinal cord injury

A study on reducing neuropathic pain in person with spinal cord injury through Laser Therapy and Periscapular stretching exercises : An Experimental Approach.

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/062013
Enrollment
200
Registered
2024-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G890- Central pain syndrome

Interventions

Intervention1: laser therapy, stretching exercise, medicine and laser therapy, medicine and stretching: laser therapy will given over back and legs stretching exercise will given to periscapular muscl

Sponsors

Chittaranjan Mishra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age – 18 years or above 2.Gender – Male, Female & Transgender 3.Pain description such as burning hot, electronic shocks , allodynia, and hyperalgia over sensory deficient area DN4 =4 4.Spinal Cord injury/Lesion conformed by MRI Scan 5.Both complete and incomplete spinal cord injury having neuropathic pain over both lower limbs

Exclusion criteria

Exclusion criteria: 1.Malignancy 2.Thyroid disease 3.Other neurological conditions 4.MusculoSkeletal pain

Design outcomes

Primary

MeasureTime frame
The numerical rating scale and for Neuropathic pain intensity is general and includes burning, electric shock pain and tingling etc. 2.Timepoint: base line, after 3 weeks, after 6 weeks

Secondary

MeasureTime frame
quality of life,Timepoint: before treatment, after 3weeks and after 6 weeks;physical activityTimepoint: before treatment, after 3 weeks, after 6 weeks;NEUROPATHIC PAIN SYMPTOM INVENTORY (NPSI)Timepoint: before treatment, after 3 weeks, and after 6 weeks;C-reactive protein testTimepoint: before treatment, after 3weeks and after 6 weeks;IL-6 and TNF-alphaTimepoint: before treatment and 3 weeks

Countries

India

Contacts

Public ContactChittaranjan Mishra

SRIHER

rsivkumar@gmail.com9840068412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026